Gene · 3003
Papers2,892
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 2,892
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CD8+ T cell-intrinsic IL-6 signaling promotes resistance to anti-PD-L1 immunotherapy. | Cell Rep Med | 2023 | 36599350 | PubTator, text mining | PubMed |
| The roles of proteases in prostate cancer. | IUBMB Life | 2023 | 36598826 | PubTator, text mining | PubMed |
| Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA. | Cancer Discov | 2023 | 36598417 | PubTator, text mining | PubMed |
| Th2 high and mast cell gene signatures are associated with corticosteroid sensitivity in COPD. | Thorax | 2023 | 36598042 | PubTator, text mining | PubMed |
| Acute posterior multifocal placoid pigment epitheliopathy following COVID-19 infection. | Am J Ophthalmol Case Rep | 2023 | 36597447 | PubTator, text mining | PubMed |
| NIAID workshop on T cell technologies. | Nat Immunol | 2023 | 36596894 | PubTator, text mining | PubMed |
| SARS-CoV2 entry factors are expressed in primary human glioblastoma and recapitulated in cerebral organoid models. | J Neurooncol | 2023 | 36595192 | PubTator, text mining | PubMed |
| Longitudinal liver sampling in patients with chronic hepatitis B starting antiviral therapy reveals hepatotoxic CD8+ T cells. | J Clin Invest | 2023 | 36594467 | PubTator, text mining | PubMed |
| Osteopontin associates with brain TRM-cell transcriptome and compartmentalization in donors with and without multiple sclerosis. | iScience | 2023 | 36594029 | PubTator, text mining | PubMed |
| Histone deacetylases inhibitor chidamide synergizes with humanized PD1 antibody to enhance T-cell chemokine expression and augment Ifn-γ response in NK-T cell lymphoma. | EBioMedicine | 2023 | 36592514 | PubTator, text mining | PubMed |
| An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia. | Nat Cancer | 2023 | 36581735 | PubTator, text mining | PubMed |
| Exploring genetic and immune underpinnings of the sexual dimorphism in tumor response to immune checkpoints inhibitors: A narrative review. | Curr Res Pharmacol Drug Discov | 2023 | 36571078 | PubTator, text mining | PubMed |
| BCG-activation of leukocytes is sufficient for the generation of donor-independent innate anti-tumor NK and γδ T-cells that can be further expanded in vitro. | Oncoimmunology | 2023 | 36567803 | PubTator, text mining | PubMed |
| Fluorogenic Granzyme A Substrates Enable Real-Time Imaging of Adaptive Immune Cell Activity. | Angew Chem Int Ed Engl | 2023 | 36562327 | PubTator, text mining | PubMed |
| The Oral Cavity Potentially Serving as a Reservoir for SARS-CoV-2 but Not Necessarily Facilitating the Spread of COVID-19 in Dental Practice. | Eur J Dent | 2023 | 36539210 | PubTator, text mining | PubMed |
| Tracking the clonal dynamics of SARS-CoV-2-specific T cells in children and adults with mild/asymptomatic COVID-19. | Clin Immunol | 2023 | 36539107 | PubTator, text mining | PubMed |
| The Single-Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast Cancer. | Adv Sci (Weinh) | 2023 | 36529697 | PubTator, text mining | PubMed |
| Spike protein receptor-binding domains from SARS-CoV-2 variants of interest bind human ACE2 more tightly than the prototype spike protein. | Biochem Biophys Res Commun | 2023 | 36525925 | PubTator, text mining | PubMed |
| COVID-19 Therapeutics: Use, Mechanism of Action, and Toxicity (Xenobiotics). | J Med Toxicol | 2023 | 36525217 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals distinct T cell populations in immune-related adverse events of checkpoint inhibitors. | Cell Rep Med | 2023 | 36513074 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3003/papers?page=44